| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |